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Abstract
Introduction: The vast difference in the abundance of different proteins in biological
samples limits the determination of the complete proteome of a cell type, requiring
fractionation of proteins and peptides before MS analysis.
Methods: We present a method consisting of electrophoresis of complex mixtures
of peptides using a strip of filter paper cut into 20 sections laid end to end over a
24-cm-long IPG strip, the pH gradient of which would drive the electrophoresis.
Peptides absorbed onto individual paper pads after electrophoresis are subsequently
recovered into a buffer solution, thus dividing a complex peptide mixture according
to pI into 20 liquid fractions. This paper-based IEF method (PIEF) was compared side-
by-side with a similar but liquid-based Offgel electrophoresis (OGE) by analyzing
iTRAQ-labeled peptide mixtures of membrane proteins from four different cell types.
Results: PIEF outperformed OGE in resolving acidic peptides, whereas OGE did a
better job in recovering relatively basic peptides. OGE and PIEF were quite
comparable in their coverage, identifying almost equal number of distinct proteins
(PIEF =1174; OGE = 1080). Interestingly, however, only 675 were identified by both of
them, each method identifying many unique proteins (PIEF = 499; OGE = 415). Thus,
the two methods uncovered almost 40% more proteins compared to what is
obtained by only one method. Conclusion: This initial investigation demonstrates
the technical feasibility of PIEF for complementing OGE. PIEF uses standard IPG IEF
equipment, requires no specialized apparatus (e.g., OGE fractionator) and may be
integrated into peptide mapping strategies for clinical samples.
Keywords: Mass spectrometry, iTRAQ, Offgel electrophoresis, Paper IEF, Progenitor
cells, Clinical proteomics
Introduction
The complexity of the human proteome, in terms of its size (over 100,000 proteins/var-
iants) and dynamic range (up to a billion-fold difference in abundance of the various types
of proteins), is well recognized [1,2]. Because MS methods preferentially identify the most
abundant proteins in complex mixtures [3], the ability to identify low-abundance proteins
by MS requires application of a variety of pre-MS techniques for depleting and/or separat-
ing out abundant proteins [4-12] as well as techniques for fractionating peptides [13-17].
Of these techniques, Offgel electrophoresis (OGE), with the capability to resolve proteins
as well as peptides by IPG IEF with subsequent liquid-phase recovery [17], is proving
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quite powerful in providing greatly improved protein coverage [18,19]. Because peptide
IPG IEF is compatible with iTRAQ [20], OGE is finding valuable applications in quantita-
tive proteomics as well [21,22]. However, OGE requires the use of a relatively specialized
OGE fractionator. Here we report the development of a similar IPG gel-driven, paper-
based IEF method (PIEF) that is equally powerful in fractionating peptides but does
not require specialized equipment. We tested the utility of PIEF by employing iTRAQ-
labeled peptide mixtures and a side-by-side comparison with OGE both in terms of
peptide recovery and proteomic coverage.
Results
Evaluating the Efficacy of PIEF
We first investigated conditions for setting up a simple gel system that could resolve
small peptides with the objective of monitoring IEF fractions of a peptide sample. As
shown in Figure 1, the gel adequately resolved different naturally occurring as well as
synthetic peptides. The utility of PIEF was first tested using a known small protein,
beta lactoglobulin (BLG), because BLG is routinely used for testing OGE (Offgel Frac-
tionator Kit Quick Start Guide). BLG predictably focused into two paper strips (filter
pads) on the acidic end of the pI 3-10 IPG strip, corresponding to its two known iso-
electric species on this strip (Figure 2). PIEF was next tested using a synthetic peptide
72109. This peptide essentially focused into one filter pad on the acidic end of the IPG
strip, correlating with its theoretical pI of 4.4 (Figure 3). Thus, PIEF yielded the
expected results for BLG and for the peptide 72109 in terms of peptide migration and
resolution. The selected peptide standards necessarily have known pI values. Although
they do not stain well with Sypro Ruby, they could be labeled with Cy3, and be used
Figure 1 Standardization of a mini SDS-PAGE gel system capable of resolving Cy3-labeled known
and synthetic peptides, loaded in increasing amounts. Lanes 1-4: angiotensin. Lanes 5-8: bradykinin.
Lanes 9-11: synthetic peptide 72109. Lanes 12-15: synthetic peptide 72120.
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to track whether they would actually migrate to the expected pI locations as deter-
mined by the underlying IPG strip. Thus we were able to optimize the PIEF buffer
composition and running conditions and establish PIEF’s basic functionality.
Figure 2 Mini gel SDS-PAGE analysis of protein fractions resulting from PIEF using a known
protein, beta lactoglobulin, and a pH 3-10 IPG strip (gel stained with Sypro Ruby). Lanes 1-17:
fractions from paper strips 1-17.
Figure 3 Mini gel SDS-PAGE analysis of peptide fractions resulting from PIEF using a Cy3-labeled
model synthetic peptide 72109 on a pH 3-10 IPG strip. Lane 1: left electrode pad fraction 1. Lane 2:
left electrode pad fraction 2. Lanes 3-14: fractions from paper strips 1-12. Lane 15: sample buffer.
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The full utility of PIEF was then tested by using iTRAQ-labeled peptide mixtures
of cytosolic proteins from four different cell samples, identifying and quantifying the
relative levels of 1,053 non-redundant proteins (minimal set of proteins excluding
duplicate identifications) at the >95% confidence level (data not shown). PIEF was
finally tested side-by-side with OGE by analyzing iTRAQ-labeled peptide mixtures of
membrane proteins from the four cell types, as described below.
Comparing the Performance of PIEF and OGE
Base peak chromatograms as presented in Figure 4, Figure 5 and Figure 6 show excel-
lent and comparable signal to noise ratios. The fact that PIEF has identified even
greater number of proteins and with greater level of confidence than OGE, using the
same instruments and identical running and analysis settings, suggests that low signal
to noise ratio is not an issue with the use of PIEF (see under section “At the protein
level”).
At the peptide level
PIEF overall identified 9, 812 peptides, of which 4,951 were non-redundant, whereas
OGE overall identified 8,141 peptides, of which 4,499 were non-redundant. As
expected, both methods recovered acidic peptides from the acidic end (fraction 1),
basic peptides from the basic end (fraction 20), and peptides with intermediate pIs
from the middle of the gel (fraction 10) (Figure 7A and 7B). The pIs of the peptides
recovered from each filter pad overall were consistent with the pI range of the underly-
ing part of the IPG strip, demonstrating successful fractionation of a complex mixture
of peptides generally according to pI. Combining the peptide lists from both methods
led to identification of 7,553 non-redundant peptides. Of these, 3,054 peptides were
exclusively detected by PIEF, the majority (~60%) appearing within the pI range 4.0-5.5
(Figure 8), whereas 2,602 peptides were exclusively detected by OGE, the majority
(~60%) appearing within pI ranges 6.0-7.0 and 8.5-10.5 (Figure 8); 1,897 peptides were
common to both methods (not shown). Thus, PIEF outperformed OGE with respect to
Figure 4 Base peak chromatograms of PIEF vs. OGE presented side-by-side showing excellent and
comparable signal-to-noise ratios. Fraction 1 of PIEF vs. Fraction 1 of OGE.
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recovery of acidic peptides, whereas OGE did a better job in resolving relatively basic
peptides.
At the protein level
PIEF identified 1,174 non-redundant proteins, and OGE identified 1,090 non-redun-
dant proteins at the >95% confidence level, resulting in a combined 1,589 non-redun-
dant proteins, with corresponding iTRAQ ratios for all of them. Although the
difference in the total number of proteins identified by these methods was only 84,
there were 499 proteins exclusively identified by PIEF and 415 proteins exclusively
identified by OGE. A total of 680 proteins were identified by both the methods. How-
ever, ratios were available for all cell-types for 675 of them, and only these have been
considered in further analysis.
Figure 5 Base peak chromatograms of PIEF vs. OGE, Fraction 10 of PIEF vs. Fraction 10 of OGE.
Figure 6 Base peak chromatograms of PIEF vs. OGE, Fraction 20 of PIEF vs. Fraction 20 of OGE.
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Figure 7 Comparative distribution of peptide pIs along the pH gradient in PIEF vs. OGE (plots A
and B, respectively). The x axis represents the rank number of peptide as the peptides were first sorted
in ascending order of pI value before plotting, and the y axis represents the pI. The x axis appears thick
because each peptide is represented by a small vertical bar (>700 such bars are juxtaposed along the axis).
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We next investigated whether the 675 proteins identified by both methods yielded
iTRAQ ratios that were comparable between methods. Because it is a common practice to
use correlation coefficients for comparing two proteomic or transcriptomic methods, we
determined the r-values between PIEF vs. OGE for iTRAQ ratios of these 675 proteins.
The results were as follows: PIEF Log HSF6: MPC 117:114 vs. OGE Log HSF6: MPC
117:114, r = 0.8987; PIEF Log HSF6 : SFC 117:116 vs. OGE Log HSF6 : SFC 117:116, r =
0.9116; PIEF Log MPC : SFC 114:116 vs. OGE Log MPC : SFC 114:116, r = 0.9100.
Although the correlation coefficients between PIEF vs. OGE methods were satisfac-
tory, they may not be reliable indicators of agreement between different methods, and
thus the use of r-values for method comparison is practically prohibited in clinical
sciences, such as clinical chemistry, as highlighted by Bland and Altman [23]. To deter-
mine the extent of agreement/disagreement between the results for PIEF and OGE, we
further analyzed our data via mean vs. difference plots of Bland and Altman (for exam-
ple, see Figure 9 for 117:116). Similar plots were obtained for the other ratios. The
standard deviations of the differences were very similar in magnitude (the equality of
the two means being expected due to the normalization procedure of the ProteinPilot
software). The Bland-Altman plot also shows that there was no systematic dependence
of the difference on the average value, indicating reasonable agreement between the
two methods over the entire range of ratios. The r-values have been included because
it is a pervasive practice. In view of the possible limitations of r values as discussed by
Bland and Altman, we wanted to demonstrate the robustness of our results by present-
ing additional evidence using Bland-Altman plot.
The most striking aspect of this comparison, however, is seen when one looks at the
list of unique proteins–i.e., identified by only one of the two methods. This result is
especially important from the perspective of uncovering expanded proteomic coverage.
Supplementary data files list the genes encoding proteins identified by both methods
Figure 8 Comparative distribution of pIs of peptides detected exclusively by PIEF or OGE (3054
and 2602 peptides, respectively).
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(Additional file 1, Table S1), exclusively by PIEF (Additional file 2, Table S2), or exclu-
sively by OGE (Additional file 3, Table S3). The Supplementary Tables include the MS
data and the associated information, such as, Accession Number, Gene Symbol, Gene
Description, N (Rank of the specified protein), Unused (ProtScore), Total (ProtScore)
and %Cov. The MS data are provided for each method and differentiated for the pro-
teins detected in common and for those detected by one method only.
IPI recognizes protein isoforms as separate entities using unique protein accession
numbers. Evaluation of Tables S2 and S3 in terms of IPI Accession Numbers vs. Gene
Symbols revealed that, of the 914 proteins that were exclusively identified by either
method, namely 499 for PIEF and 415 for OGE, 129 were protein isoforms whereas 784
were products of distinct genes; i.e., 86% of the total were distinct gene products. In any
case, the purpose of application of the Bland and Altman plots is to assist in the compar-
ison of different assays, thereby defining an optimum assay(s) for a particular analysis.
Table 1 summarizes the results from Supplementary Data tables (Tables S1-S3). The
results show, a) PIEF consistently outperformed OGE by not only identifying a greater
number of proteins but also by increased level of confidence with which they are iden-
tified, and b) the proteins identified by both methods are identified with a higher level
of confidence by both methods in comparison to proteins identified by one method
alone. Overall, our data demonstrate that PIEF and OGE cannot substitute for one
other; rather, the methods are complementary.
Accuracy of iTRAQ Ratios
Known amounts of a particular complex protein mixture were differentially labeled,
multiplexed, and processed through all the steps of OGE prior to MS analysis. In
Figure 9 Bland and Altman (mean vs. difference) plots showing the level of agreement of iTRAQ
ratios for 675 proteins identified by both PIEF and OGE.
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Figure 10, the proteins identified (801 proteins out of perhaps thousands present in the
sample) are shown on the x axis, and the iTRAQ ratios are on the y axis. The observed
mean ratio vs. expected ratio was 0.051 vs. 0.200 (in case of iTRAQ label 114), 0.641
vs. 0.600 (in case of 115), and 1.402 vs. 1.400 (in case of 117). The experimentally
observed ratios were systematically lower when the theoretical ratios were low (i.e., 0.2,
based on the amounts added; Figure 10, top panel). However, comparing the three
panels in Figure 10 actually shows that increasing the amount of protein in the
numerator (keeping the amount of protein in the denominator constant) increased the
agreement between the expected and experimental ratios. Thus, the higher the abun-
dance of protein measured (in absolute amount) in samples being compared, the
greater the agreement between the expected and the experimental ratios (Figure 10).
We did not perform this analysis using PIEF due to limitations of laboratory resources.
Discussion
Protein-level Fractionation Alone is Insufficient for Complete Proteomic Analysis
Two critical factors limit the identification of low-abundance proteins in proteomic
analyses: differences in protein abundance, and the yield of diagnostic peptide frag-
ments during MS analysis. A variety of methods exist for fractionation of proteins
before MS analysis to facilitate detection of low-abundance proteins (for review, see
[7,12]). These methods include separation based on cellular organelles (e.g., cytosolic,
plasma membrane, nuclear, and cytoskeletal fractions), affinity purification, and bio-
chemical properties like hydrophobicity, MW, pI, and high-resolution 2-D PAGE that
combines MW and pI [24], although 2-D PAGE is not amenable to shotgun proteo-
mics. Yet, these methods are not sufficient for in-depth proteomic analyses because
the complexity generated following tryptic digestion of proteins is completely indepen-
dent of the level of complexity that existed at the protein level. As reported earlier [25]
for example, 11% (80 of 712) of proteins in the MPC proteome generated 50% of the
peptides (5,258 of 10,506) that were detected during LC-MS/MS of the MPC pro-
teome. This peptide-rich fraction of the MPC proteome would potentially hinder
detection of low-abundance and small proteins, because the latter necessarily generates
a small fraction of the peptides in the total MPC proteome. Higher coverage of the
proteome may be achieved by combining fractionation both at the protein and peptide
levels. In the present study, proteins were first fractionated based on subcellular loca-
tion, followed by fractionation of peptides based on pI, which indeed greatly enhanced
the proteomic coverage in comparison to the previous study [25].
Table 1 Summary of average MS data scores for proteins identified by OGE and PIEF












Proteins Common to PIEF and OGE
(675) (Table S1)
20.73 23.64 9.28 10.70 8.78 10.13
Proteins Unique to PIEF (499) (Table
S2)
N/A 14.66 N/A 4.79 N/A 4.54
Proteins Unique to OGE (415) (Table
S3)
14.09 N/A 4.58 N/A 4.38 N/A
N/A: not applicable
See Supplementary Data Tables S1-S3 for lists of individual proteins with the associated MS data, from which the above
average-scores were obtained. The MS scores reflect on the confidence with which the proteins are identified. See
Results for an interpretation of the findings.
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Methods of Peptide Fractionation
Traditionally, 2-D LC-MS/MS analysis of peptides entailed SCX followed by reversed-
phase chromatography [26]. Because of limited resolution of SCX, IPG IEF was devel-
oped in place of SCX [15]. However, IPG-IEF requires excision of small sections of the
IPG strip followed by extraction of peptides in the gel matrix. Consequently, a more
elegant IPG gel-driven but liquid-based OGE was described [17]. However, OGE
requires a specialized apparatus–the OGE fractionator. Here we describe PIEF that
Figure 10 Controlled quantitation study to test the accuracy of iTRAQ ratios. The x axis represents
the rank number of protein as the proteins were first sorted in descending order of iTRAQ ratio before
plotting, and the y axis represents the iTRAQ ratio. The x axis appears thick because each protein is
represented by a small vertical bar (>800 such bars are juxtaposed along the axis).
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uses standard equipment. However, PIEF and OGE surprisingly provided very different
results when applied to iTRAQ-labeled membrane protein samples (see below). This
suggests that either method alone is insufficient and rather that they are complemen-
tary. In any event, these methodologies will certainly require further investigation
because OGE thus far has stood alone without being challenged, except for a single
comparative study that actually found reversed-phase HPLC at high pH to be superior
to OGE [27].
Possible Reasons for Disparate Results between PIEF and OGE
PIEF and OGE outputted significantly different results in several respects. Each method
recovered large numbers of unique peptides; PIEF did a better job at recovering/identi-
fying acidic peptides, whereas OGE identified a greater number of basic peptides. In
fact, for many of the proteins that were identified by both methods, the magnitudes of
the corresponding iTRAQ ratios seemed to be significantly different. The possible rea-
sons for the disagreement between the results by PIEF and OGE may be several-fold.
Neither PIEF nor OGE may be optimal because substantial amounts of sample pep-
tides were left behind in the IPG gel matrix, as assessed by imaging of Cy3-labeled
peptides remaining in the IPG strips after either analysis (results not shown). To our
knowledge, OGE has not been investigated from this perspective. We do not know
whether there was differential retention of different peptides because we did not quan-
tify the peptides that were retained in the gel matrix. Differential retention and/or
non-uniform extraction could potentially impact the iTRAQ ratios. These issues
remain to be investigated.
Four additional reasons for differences between PIEF and OGE are discussed here.
These reasons were unavoidable as it can be realized from the following discussion.
First, we had to use different IEF/extraction media, 4M urea/10% glycerol/0.5% ampho-
lytes for Offgel as recommended by the manufacturer, and 7M urea/2M thiourea/1%
DTT/1% ampholytes for PIEF. Because the Offgel IEF medium was found to be subop-
timal for PIEF during initial trials, we used the latter medium for PIEF. Such wide che-
mical difference may well explain some differences in the performance of OGE vs.
PIEF. Second, the gaps between pads in PIEF and the gaps between wells in OGE may
not necessarily correspond with each other, and the peptides migrating to those loca-
tions are essentially lost to analysis. Imaging of the post-run IPG strip after completion
of IEF using Cy-labeled peptides showed bright bands representing these junctions
(data not shown). PIEF experiments using one long uncut paper strip spanning the
length of the IPG strip, or using small pads (as was done here) but leaving no gaps in
between them, were unsuccessful due to poor fractionation (data not shown). Because
it would be cumbersome to cut a long strip of wet paper after IEF, we first tried the
method with 20 pads and it proved to be the best approach in terms of resolution. We
believe that one long strip of paper spanning the entire length of IPG gel somehow
interferes with the underlying electrophoresis, or that peptides once they are absorbed
onto the filter paper transform the paper into a parallel conducting medium; the
absence of gaps compromises resolution. When gaps are present, however, once pep-
tides have migrated to their pI point and are absorbed to the corresponding pad they
are probably trapped. The decision to use 20 pads was based on cost and the labor
required on one hand and the extent of desired fractionation on the other, because the
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better the resolution the greater the proteomic coverage. Because each of the 20 frac-
tions represents a separate MS study with associated costs, we thought 20 fractions
would be experimentally manageable. Third, the efficiencies of peptide extraction by
PIEF and OGE, even from the functional locations of the gel (i.e., the gel areas corre-
sponding to pads in the case of PIEF and to wells in the case of OGE), may not be
high as alluded to above, and consequently the data may not necessarily be compar-
able. Finally, for PIEF the peptides were mechanically extracted by vortexing the paper
pads, whereas for OGE the peptides were allowed to spontaneously diffuse into the IEF
running buffer. These issues may not apply to reversed-phase HPLC at high pH or
conventional SCX chromatography, but of course SCX yields relatively poor resolution
and consequently lower coverage.
Accuracy and Precision Issues Inherent to iTRAQ Quantitation
The overall differences in the results outputted by PIEF vs. OGE were probably com-
pounded by the variability inherent to iTRAQ quantitation. A number of reports have
addressed the issues of iTRAQ quantitation accuracy (defined as being close to the
true value and measured by statistical mean) and precision (defined as reproducibility
and measured by standard deviation) [28-32]. The variability in iTRAQ ratios can be
potentially related to various peptide properties that include abundance, length,
sequence, mass, etc. More specifically, it has been reported that iTRAQ is sensitive to
errors in precursor ion selection in comparison to ICAT and DIGE, suggesting mass
spectrometer-related interference could introduce substantial random variation [32].
Our own observations suggest that the agreement between the expected and the
experimental ratios correlates with the abundance of protein measured (in terms of
absolute quantity) in samples being compared (Figure 10), suggesting that protein
abundance is fundamental to the reliability of the relative quantitation. In any event,
the primary focus of the present investigation was on maximizing the coverage. To this
end, we attempted to characterize as many different subproteomes as possible, rather
than making replicate measurements on the same sample; this approach is consistent
with the practice reported in most studies of this type. We were able to identify and
quantify relative amounts of ~4,750 non-redundant proteins by studying 200 subpro-
teomes (10 fractions at the protein level, with each protein fraction further fractionated
into 20 peptide-level subproteomes) across four different cell types (results to be pub-
lished). These results are in contrast to those from our earlier study in which there
was no fractionation at the protein level, and SCX fractionation was used at the pep-
tide level; that study identified only 900 proteins [25].
Potential Applications of PIEF
The primary purpose of developing PIEF was to decrease the complexity of proteomic
samples by fractionating each individual sample at the peptide level, thereby enhancing
the coverage of the proteins identified. Because PIEF uses standard IPG IEF equipment
and thus requires no specialized equipment like the OGE fractionator, it may be routi-
nely integrated into standard proteomic workflow, thus lending PIEF to widespread
applications, including peptide-mapping studies involving human body fluids [33].
The peptide SDS-PAGE system provided a direct and relatively inexpensive method
to monitor the initial performance of PIEF as well as OGE before MS analysis of
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complex mixtures of peptides. Although Sypro Ruby staining of the gels was not parti-
cularly helpful for detection of peptides (probably because of its lower sensitivity), Cy3
labeling of peptides proved to be powerful (Figures 1 and 3). Following Cy3 labeling, a
particular peptide migrates to its pI region and is absorbed onto the paper pad,
whereas the free dye migrates to the basic end of the gel and is absorbed onto the
paper pad placed over the right end of the gel. This finding suggests a means to pre-
pare labeled peptides free of unbound dye molecules.
PIEF could potentially be used for preparative-scale purification of isoelectrically
equivalent forms of peptides employing first a broad pH-range IPG strip (e.g., pH 3-
10) and then perhaps a narrow pH-range strip as relevant to the peptide(s) of interest.
The success of the method could be monitored by peptide SDS-PAGE, as described
above.
In conclusion, a substantial number of proteins were detected by OGE but missed by
PIEF, and vice versa. Pooling data from several such complementary fractionation
methods is likely to provide a much better experimental estimate of the proteome size.
Methods
All studies were conducted according to the Institutional Review Board policies and
practices of the Los Angeles Biomedical Research Institute.
Cell Culture
Normal bone marrow samples were obtained from healthy volunteers at the Hemato-
poietic Stem Cell Facility at Case Western Reserve University Comprehensive Cancer
Center. Human marrow stromal mesenchymal stem cells (MPC) were culture-
expanded using a marrow aspirate sample from a 25-year-old normal white male, and
MPC were purified using a Percoll gradient as described [34]. Human embryonic stem
cells HSF6 (XX, 46, NIH no. UC06) were maintained on irradiated CF1 murine
embryonic fibroblasts in Knockout Dulbecco’s modified Eagle Medium supplemented
with 20% knockout serum replacer (Invitrogen, Carlsbad, CA), fibroblast growth fac-
tor-2 (4 ng mL-1), 1 mM [L-glutamine, 0.1 mM nonessential amino acids, and 0.1 mM
2-mercaptoethanol with daily medium changes, and passaged every 4-6 days by incuba-
tion with 1 mg mL-1 dispase/collagenase IV (Invitrogen) for 12-18 min at 37°C. Adult
human dermal fibroblasts were obtained commercially (Lonza, Inc, Walkersville, MD)
and were expanded according to the manufacturer’s instructions using fibroblast cell
basal medium supplemented with 2% fetal bovine serum, 0.1% insulin, 0.1% gentamy-
cin and amphotericin, and 0.1% fibroblast growth factor-beta.
Protein Fractionation and Subsequent Sample Cleanup
Each of the four cell samples, namely, purified MPC, unpurified stromal cells (USC),
HSF6 (H6C), and skin fibroblast cells (SFC), was fractionated into cytosolic, membrane,
nuclear, and cytoskeletal protein fractions, referred to as q-proteome fraction 1 (QF1),
QF2, QF3 and QF4, respectively, using the Q-Proteome Cell Compartment kit (Qiagen
Inc, Valencia, CA) and following the manufacturer’s instructions with additional pro-
tease inhibitors. The fractionated proteins were acetone-precipitated using four
volumes of cold acetone, and incubated for 2 h at -20°C and overnight at 4°C [35].
Protein precipitates were collected by centrifugation at 21920 × g at 4°C for 30 min
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using 2-mL tubes in a Microfuge 22R Centrifuge (Beckman Coulter, Brea, CA) or at
22000 × g at 4°C for 30 min using 15-mL tubes in a Avanti J25 (Beckman Coulter)
and air-dried for 15-30 min. Protein pellets were stored at -80°C. Before use, protein
precipitates were resolubilized and proteins were reduced with tributylphosphine
(Sigma, St. Louis, MO) and alkylated with acrylamide using a reduction/alkylation kit
(Proteome Systems, Woburn, MA). Protein concentrations were estimated using an
assay that avoids interference from reducing agents and detergents (reducing agent
compatible and detergent compatible (RC DC) Protein Assay, Bio-Rad, Hercules, CA).
A measured amount of a reduced/alkylated protein sample in 1 mL was desalted by
performing three rounds of centrifugation at 4000 × g for 60 min at 25°C, using Ami-
con Ultra-4 Centrifugal Filter Units (Millipore, Billerica, MA), an Allegra 25 R centri-
fuge (Beckman Coulter) with 15-mL swinging buckets, each time diluting the sample
in 3-4 mL deionized solution of urea (8.75 M)/thiourea (2.5 M) and generating a reten-
tate volume of 250-500 µL. After final centrifugation, the sample proteins were acet-
one-precipitated into 800 µg or 110 µg aliquots and stored at -80°C.
We have been aware that the precipitate of membrane proteins with organic solvents
would not re-dissolve readily. As outlined above, we circumvented this problem by
pre-aliquoting the sample proteins in the amount (110 μg) as required for subsequent
labeling with a given iTRAQ reagent and then precipitating the protein sample using
acetone. As described below, the precipitate was re-dissolved using Invitrosol (LC/MS
Protein Solubilizer, a surfactant blend, Invitrogen, Inc.) in triethylammonium bicarbo-
nate buffer, followed by trypsin digestion. Even if one were to assume dissolution was
incomplete, trypsin will digest the protein anyway. The completion of digestion was
routinely tested by SDS-PAGE gel.
Tryptic Digestion of Proteins, iTRAQ Labeling and Multiplexing of Peptides, and
Subsequent Sample Cleanup
Aliquots of acetone-precipitated samples (110 µg assuming ~10 µg loss during these
processes) were resuspended in 40 µL of 5× Invitrosol without ammonium bicarbonate,
40 µL of 125 mM triethylammonium bicarbonate buffer, pH 8.5 and 120 µL of H2O.
Samples were vortexed for 1-2 min and incubated at 60°C for 5 min, followed by vor-
texing for 1-2 min. They were then incubated at 60°C for 10 min, followed by sonica-
tion for 30 min. Proteins were digested using 5 µg of trypsin per 100 µg of sample
protein and incubating at 37°C overnight. Digestion was terminated by adding TFA
(0.5% final concentration) to the samples. The peptides were vacuum-dried and stored
frozen at -80°C. iTRAQ labeling of the peptide samples was performed using the
iTRAQ Reagents Multiplexing kit [36] according to the manufacturer’s instructions
(Applied Biosystems, Inc., Foster City, CA). The samples were labeled as MPC-114,
USC-115, SFC-116, and H6C-117 (depending on the iTRAQ reagent used) and were
multiplexed and vacuum dried. Desalting of the vacuum-dried peptide samples was
carried out using OASIS extraction cartridges (Waters, Milford, MA). Briefly, the pep-
tide sample was resolubilized in 1 mL of 0.1% TFA and passed through a column con-
ditioned with 1 mL of 100% ACN and equilibrated with 1 mL of 0.1% TFA. The
bound peptides were first washed with 4 mL of 0.1% TFA followed by 800 µl of H2O,
and eluted using two rounds of 250 µl of 70% ACN. Initially, cytosolic protein samples
(QF1’s) were used to test the utility of PIEF. Next, membrane proteins (QF2’s) were
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used to compare PIEF with OGE. For the purpose of comparison, the eluted peptides
at this stage were equally divided, keeping the technical variables constant thus far.
The peptides were then dried and resolubilized in IEF sample buffer, followed by appli-
cation to PIEF and OGE.
Fractionation of iTRAQ-labeled Peptides using PIEF
PIEF was performed using the IPGPhor system and 24-cm IPG strips, pH 3-10 (GE
Healthcare, Piscataway, NJ). Notably, an IPGphor strip holder with cup loading (GE
Healthcare) was used instead of regular strip holders, although no cup loading of the
samples was employed. The IEF strip was rehydrated in a rehydration tray overnight at
room temperature (RT) in 450 µl of an IEF buffer (7 M urea/2 M thiourea/1% DTT/
1% 3-10 ampholytes) with gel face down and overlaid with 1.5 mL of dry strip cover
fluid (GE Healthcare). Each rehydrated strip was transferred to a strip holder with the
gel side facing up, as is done for a cup-loading setup, so that paper pads could be
placed in direct contact with the gel surface. Strips of filter paper (GE healthcare 18-
1004-40) were cleanly cut in advance into 10 mm-long IEF electrode strip pads using a
paper cutter (FISKARS). The strip pads were then wetted on a glass plate with 2 drops
of IEF buffer for each pad using a 1-ml pipette, and they were finally laid end to end
on top of the IPG strip, with the first pad beginning at the + sign of the strip and leav-
ing a ~1-mm space between the pads. The strip pads were not necessarily from one
strip, but from two or more strips of the same lot number. Sample solution prepared
using 450 µl IEF buffer was loaded in the central 10 pads by adding 40-45 µl of sample
on top of each pad until the entire sample was loaded. Then 40-45 µl of IEF buffer
(without sample peptides) was added to the remaining peripherally located pads. Pads
were gently pushed against the gel. Two 5 mm-long IEF electrode pads were wetted
with deionized H2O, followed by blotting the excess water with Kim Wipes and then
placing one pad at each end of the IPG strip. The electrodes were positioned at each
end such that they were on top of the electrode pad with IPG gel underneath. Dry
strip cover fluid (3 ml) was added on top of the pads. IEF was run under the condi-
tions as outlined in Table 2.
At the day’s end when the run reached Step S4, the electrode pads were replaced
with fresh ones (5 mm long) wetted with deionized H2O and blotted almost completely
dry on KimWipes. If necessary, 1.5 ml of dry strip cover fluid was added and the run
was restarted by creating a new program with conditions as shown in Table 3, chan-
ging Step S1 according to the stage when S4 was stopped such that the run entails a
total 63kV-h including both phases.
After the run, each of the 20 paper pads was transferred to a 2-ml tube containing
200 µl of extraction buffer (7 M urea, 2 M thiourea) and were vortexed vigorously for
30 s followed by centrifugation at 21920 × g at 20ºC for 5 min using a Microfuge 22R
centrifuge (Beckman Coulter). The solution was recovered by pressing the pad using a
Table 2 Running conditions for IEF Phase I
S1 Step and hold 500 V 0.5 kV-h
S2 Gradient 1000 V 1.0 kV-h
S3 Gradient 8000 V 13.5kV-h
S4 Step and hold 8000 V 60kV-h
S5 Step and hold 500 V 20 h
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pipette tip. The extraction was repeated (x2), and the extracted samples from each pad
were pooled and then purified using C18 columns (The Nest Group Inc., Southboro,
MA) before running MS.
Fractionation of iTRAQ-labeled Peptides Using OGE
OGE of peptides was carried out using 24-cm IPG strips, pH 3-10 (GE Healthcare),
and an OGE fractionator [17] (Agilent Technologies, Inc.) according to the instructions
accompanying the equipment. IEF strip was placed on an OGE tray, gel face up, fol-
lowed by the placement of the frame. Modified Offgel IEF buffer (150 µl; 4 M urea/
10% glycerol/0.5% 3-10 ampholytes) was added per well. Electrode pads were wetted in
Offgel IEF buffer and placed at both the ends of the strip. Offgel IEF buffer, 200 µl or
400 µl, was added to the left and right protruding wells, respectively. Prehydration was
carried out for 5 h at RT on the leveled Offgel platform. At the end, the residual Offgel
IEF buffer was removed by pipetting, and the electrode pads were removed. The tray
was laid in a slanted position with the right protruding end at a higher level. The Off-
gel IEF buffer beneath the strip was removed by adding 600 µl mineral oil to the right
protruding end such that the Offgel IEF buffer gravitated to the left end. New elec-
trode pads freshly wetted in Offgel IEF buffer were placed at both the ends. The Offgel
IEF buffer was removed from all the wells, and 150 µl of peptide sample prepared in
Offgel IEF buffer was added to each well. Mineral oil, 200 µl or 400 µl, was added to
the left and right protruding wells, respectively. The cover seal was placed, and the
tray was moved to the Offgel fractionator platform. The fractionator was run under
the following conditions: 50 kV-h, 8000 V, 50 µA, and 200 W. At the end of the run,
the samples were processed as follows. The first five samples (1-5) were collected in
one tube. The left electrode pad and right electrode pad were transferred to two sepa-
rate tubes that contained 100 µl of Offgel IEF buffer. The electrode pads (left and right
electrode pad) were processed as follows:
1) Vortex vigorously for 30 s
2) Centrifuge at 21000 rpm for 5 min at RT (Microfuge 22R Centrifuge, rotor
F301.5)
3) Recover the solution by squeezing the pad
The extracted solution from the left electrode pad was pooled with OG5 (OGE well
5), and the solution from the right electrode pad was pooled with OG24 (OGE well
24), thus generating a total of 20 fractions. The OGE fractions were purified similar to
PIEF fractions using C18 columns prior to MS.
C18 Spin Column Purification
Peptide fractions resulting from PIEF and OGE were cleaned up before MS runs using
Vydac C18 silica microspin columns (The Nest Group, Inc.). Briefly, the column was
conditioned with 100 µL of 100% ACN by centrifuging at RT at a low speed about
Table 3 Running conditions for IEF Phase II
S1 Step and hold 8000 V 23 kV-h
S2 Step and hold 500 V 20 h
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100 rpm for 1 min (Microfuge 22R Centrifuge, rotor F301.5), followed by flushing out
of ACN with 100 µL of H2O twice by centrifuging at RT at about 3000 rpm for 1 min.
TFA (2%) was added to the sample to a final concentration of 0.1%, and the peptides
were allowed to bind to the column by centrifuging at RT at 2000 rpm for 2 min. The
bound peptides were washed with 50 µL of 0.1% TFA twice by centrifuging at RT at
2000 rpm for 1 min. Finally, the peptides were recovered using three rounds of elution
with 100 µl of 98% ACN, 2% H2O and 0.1% formic acid. Our practice of purifying
PIEF fractions using C18 spin columns effectively removed any “dust” potentially origi-
nating from the filter paper, and the subsequent vacuum drying of samples eliminated
any dilution effect (see under Results).
Cy3 Labeling of Peptides
Cy3 labeling of synthetic peptides as well as complex mixtures of peptides was carried
out as described for Cy3 labeling of proteins [35].
Peptide SDS-PAGE
Conditions were standardized to allow in-lab monitoring of PIEF and OGE to ensure
that each procedure proceeded appropriately. Known peptides as well as synthetic
peptides with known or predicted pIs were used for this purpose. The peptides
tested were as follows: angiotensin (computed pI 6.92 and MW 1296.49), and brady-
kinin fragment 1-7 (pI 9.75, MW 756.86) (both from Sigma, A9650 and B1651,
respectively), and synthetic peptides 72109 and 72120 (both from GenScript, Inc.).
Their amino acid sequences, pIs and MWs were as follows: 72109 WK-11: Trp-Val-
Gln-Asp-Ser-Met-Asp-His-Leu-Asp-Lys (WVQDSMDHLDK), pI 4.36-4.41, MW
1373.5, and 72120 GK-10: Gly-Tyr-Ser-Ile-Phe-Ser-Tyr-Ala-Thr-Lys (GYSIFSYATK),
pI 8.4-8.5, MW 1136.27.
A premade 12% Bis-Tris gel with a 15-well format (Invitrogen) was found to be the
best for this task. A lab-made 2× (0.575%) or 4× (1.15%) lithium dodecyl sulfate sample
buffer was used, and a 2× buffer consisted of 0.575% lithium dodecyl sulfate (w/v), 20%
glycerol and 125 mM Tris, pH adjusted to 6.8 [37]. No dye was included. The samples
were prepared such that the final sample solution contained 1× sample buffer and 1×
NuPAGE sample reducing agent and were heated at 70°C for 10 min before loading.
The gels were run for 30 min using the Mini SureLock system with 500 ul NuPAGE
anti-oxidant added to the inner chamber. One well received 1× sample buffer contain-
ing tracking dye (but no peptides) to monitor the progression of electrophoresis. The
gels were fixed in 40% methanol, 1% glacial acetic acid and 59% distilled/deionized
H2O for 1-2 h. Gels were stained with Sypro Ruby (Invitrogen) if the peptides used
were unlabeled, or imaged using a Typhoon 9410 imager (GE Healthcare) or Molecular
Bio-imager (Bio-Rad) if the peptides used were Cy labeled.
MS
The iTRAQ-labeled and multiplexed peptide samples after fractionation using PIEF
and OGE were vacuum-dried and shipped to the University of Victoria Genome BC
Proteomics Centre, Victoria, BC, Canada, where LC-MS/MS was carried out on a
hybrid Quadrupole-TOF LC-MS/MS Mass Spectrometer (QStar Pulsar i), as in our
previous study [25].
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Primary Data Analysis
The objective of the overall project was to determine the utility of PIEF and its rela-
tive performance against OGE. Each of the PIEF and OGE datasets was analyzed at
the protein level for iTRAQ ratios and at the peptide level for pIs. ProteinPilot Soft-
ware v2.0 (an updated and integrated version of ProQuant and ProGroup Viewer
software applications) and the Paragon method [38] (Applied Biosystems MDS
SCIEX) were used to analyze the MS data (.wiff files) to identify and quantify pro-
teins resolved by LC-MS/MS [25]. Bias correction was applied prior to the analysis
to correct for differences in total amounts of proteins across samples. The software
determines the median average protein ratio and adjusts it to unity and then applies
this correction factor to all quantitative results. iTRAQ peptide data were used to
search the International Protein Index (Human IPI v. 3.43) protein database. Only
proteins that were identified at the >95% confidence level were included in subse-
quent analysis by exporting the protein summaries as Excel files. Because ProteinPi-
lot was not equipped to provide pI values of the peptides identified, the MS data (.
wiff files) were also analyzed using Spectrum Mill Software (Agilent Technologies),
aided by QSTAR Data Extractor, and applying the relevant iTRAQ isotope correc-
tion factors, and searching the Human IPI protein database (v. 3.43). Peptide sum-
mary data, including the pI values, were exported as Excel files using the Excel
Export feature of Spectrum Mill.
Mining Peptide-level pI Data using GeneSpring Software
The use of GeneSpring to mine proteomic data was described earlier [25]. Briefly, the
peptide summaries obtained from Spectrum Mill, including columns of information
specific for individual peptides, were used to create a custom peptide genome. The col-
umns included: sequence, peptide pI, and others. The custom genome encompassed all
the peptides (17,953), identified by PIEF and OGE. Data for each experiment (PIEF
and OGE) included columns unique to the experiment, namely file name, and fraction
number, as well as sequence, with the sequence column being in common with the
custom genome. Thus, sequence was used as a systematic name for analysis using
GeneSpring (GX 7.3.1). This allowed us to create lists of peptides (excluding dupli-
cates) detected by both methods as well as the peptides exclusively detected by PIEF
or OGE, including the pI values associated with each peptide.
Mining the Protein-level iTRAQ Data using GeneSpring Software
The IPI protein database, consisting of 72,346 IPI Accession Numbers (representing
approximately 24,637 genes) including their gene symbols and other annotations, was
used to create a custom protein genome. This required conversion of the IPI database
file, first into an Excel file and then into a text file, followed by importing into Gene-
Spring as a custom genome. Data for each experiment included columns of ratios
based on the iTRAQ reagents used 117:114, 117:116, 114:116, and 114:117, as well as
gene symbol, with IPI Accession Number being in common with the custom genome.
The IPI Accession Number was thus used as the systematic name for GeneSpring ana-
lysis purposes. This allowed intersecting of PIEF and OGE protein lists and creating
the lists of proteins uniquely detected by each of these methods, as well as the proteins
detected by both methods, including their associated iTRAQ ratios. The entire
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sequence of experimental steps in evaluating the performance of PIEF vs. OGE is out-
lined in Additional file 4.
Controlled Testing for the Accuracy of iTRAQ Ratios
To check the reliability of the relative ratios of protein amounts across the four differ-
ent samples outputted by iTRAQ labeling, a preliminary controlled quantitation study
was performed. Known total amounts (25 µg, 75 µg, 125 µg and 175 µg) of a particular
protein mixture (consisting of MPC proteins, pI range 5.4-6.2, isolated using a Zoom
IEF fractionator) were analyzed using established methods [25,35] (Additional file 4).
Briefly, the four protein samples were digested with trypsin, and peptides were differ-
entially labeled with four iTRAQ reagents, 114, 115, 116 and 117, respectively, and
multiplexed, followed by desalting using Oasis solid-phase extraction columns and
fractionating into 20 fractions according to pI using IPG strip pH 3.0-10.0 and OGE.
This study was conducted using only OGE, and PIEF was not performed (due to lim-
itations of laboratory resources and funding). Peptide fractions were purified using C18
spin columns, and eluates containing peptides were divided into two aliquots and sub-
jected to two rounds of reversed-phase LC-MS/MS, with the second run excluding the
peptides identified during the first run. Data analysis was performed using ProteinPilot
v2.0. Bias correction was not performed because the objective of this particular analysis
was to quantify differences purposely introduced into the samples.
Additional material
Additional File 1: Table S1. Proteins Common to PIEF and OGE. The Supplementary Tables include the MS data
and the associated information, such as, Accession Number, Gene Symbol, Gene Description, N (Rank of the
specified protein), Unused (ProtScore), Total (ProtScore) and %Cov. The MS data are provided for each method and
differentiated for the proteins detected in common and for those detected by one method only. Based on the
ProteinPilot software user manual, the data attributes may be defined as follows. N represents the rank of the
specified protein in relation to the rest of the proteins in the list of detected proteins. Unused (ProtScore)
represents a measure of protein confidence for a detected protein calculated using only peptides from spectra
that have not already been used by higher scoring winning proteins. Notably, once a spectrum is used to identify
a protein, it cannot be used to identify any other proteins. The Unused ProtScore is thus the key to how the
software identifies proteins. A “good” Unused ProtScore corresponds to the set level of confidence. For 95%
confidence, the required Unused ProtScore is 1.3 that is a default in a Paragon Method. Only proteins that show
>95% confidence are considered in our study. Total (ProtScore) for a particular protein is calculated using all of its
peptides and does not necessarily indicate the percent confidence for the identification of a protein. %Cov
represents the percentage of the number of amino acids matching to at least one identified peptide divided by
the total number of amino acids in the protein sequence.
Additional File 2: Table S2. Proteins Unique to PIEF
Additional File 3: Table S3. Proteins Unique to OGE
Additional File 4: Schematic. Flow diagram outlining the essential steps of sample preparation, cleanup and
concentration in comparing the performance of PIEF vs. OGE
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